市场见解

Analysts name 2 excellent ASX growth shares to buy right now

Here are two ASX growth shares that are rated highly…
The post Analysts name 2 excellent ASX growth shares to buy right now appeared first on The Motley Fool Australia. –

Looking for some additions to your portfolio? Listed below are two ASX growth shares that have been given buy ratings.

Here’s why analysts rate them highly right now:

Breville Group Ltd (ASX: BRG)

The first ASX growth share to look at is Breville. It is the leading appliance manufacturer behind the Sage, Kambrook, Baratza, and Breville brands.

Thanks to its ongoing investment in product development, Breville’s brands have been resonating extremely well with consumers for many years. This has been underpinning solid sales, earnings, and dividend growth.

The good news is that this solid form looks set to continue due to the strength of its product portfolio, favourable trading conditions and consumer preferences, and its ongoing global expansion.

Morgans is a big fan of Breville. While it acknowledges that its shares are not cheap, it believes the premium is justified given “the prospect for multi-year, globally-derived organic revenue growth at or above 10%.”

The broker currently has an add rating and $34.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another ASX growth share that could be in the buy zone is ResMed.

It is a medical device company with a focus on sleep treatment and respiratory products that treat disorders including sleep apnoea and chronic obstructive pulmonary disease (COPD).

These are significant and growing markets to target. For example, upwards of 1 in 5 people are believed to suffer from sleep apnoea, with the vast majority currently undiagnosed. This bodes well for ResMed’s future growth, particularly given its industry-leading products, high level of research and development, and wide distribution network.

Another positive for the company is the recent product recall by its biggest rival Philips. An update this week reveals that the Dutch healthcare giant has now expanded its recall to 5.2 million devices from 3 million to 4 million. This is expected to tie Philips up with repairs for some time and also damage its brand.

Macquarie is positive on the company. It currently has an outperform rating and $39.00 price target on ResMed’s shares.

The post Analysts name 2 excellent ASX growth shares to buy right now appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

More reading

3 fantastic ASX growth shares rated as buys

3 excellent ASX shares for growth investors in January

Here’s what this broker thinks of the ResMed (ASX:RMD) share price

5 things to watch on the ASX 200 on Monday

3 buy-rated ASX growth shares

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Life360, Inc. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!